The HHS Office for Civil Rights is investigating whether patient data were exposed in the cyberattack on Change Healthcare; a new study claims that the US’ high maternal mortality rates are the product of flawed data; HHS secretary is open to drug testing recipients of welfare.
HHS Opens Probe Into Privacy Impacts of Change Healthcare Cyberattack
The HHS Office for Civil Rights has opened an investigation into whether the cyberattack on Change Healthcare involved patients’ protected health information and whether the claims processor sufficiently protected patient privacy, according to the Associated Press. The attack in late February brought down the systems of Change Healthcare, a unit of UnitedHealth Group, wreaking havoc on billing and reimbursement, though the company said Wednesday that its major pharmacy and payment systems were back online. The Office for Civil Rights, which enforces federal privacy and security laws for patients’ health information, said its probe was spurred by the “unprecedented magnitude” of the ransomware attack.
Flawed Data to Blame for Apparent High Maternal Mortality Rates in US, Study Claims
New study findings could upend the notion that the US has an especially high and rising maternal mortality rate, claiming that the trend is a result of incorrectly classified data, The Hill reports. Published in the American Journal of Obstetrics & Gynecology, the study reports that deaths are considered maternal mortality events if the “pregnancy” box is checked on a death certificate, but this box was at times checked erroneously, including for hundreds of people older than 70 years. The researchers noted that despite the misclassified maternal deaths, racial and ethnic disparities in maternal mortality persist, including disproportionately high rates among Black women.
Amid Fentanyl Crisis, HHS Secretary Doesn’t Rule Out Drug Testing Welfare Recipients
Speaking at Politico’s Health Care Summit, HHS Secretary Xavier Becerra seemed open to the idea of requiring drug testing for recipients of welfare benefits. Considering the severity of the substance use epidemic, driven largely by fentanyl overdoses, Becerra said he wouldn’t dictate what actions cities, counties, or states should take; instead, all options should be left on the table. Such a measure was approved by San Francisco voters earlier this month, indicating how even heavily Democratic municipalities are turning to tougher policies to combat the tide of substance use.
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
Cardiovascular Magnetic Resonance Highlights Sex-Specific Characteristics in Aortic Stenosis
February 19th 2025This multicenter study sheds more light on sex-based differences in aortic stenosis (AS) and argues the benefits of using cardiovascular magnetic resonance (CMR) to assess sex-based risks in AS.
Read More